| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.13B | — | +2.7% |
| Cost of Revenue | $1.32B | — | +1.6% |
| Gross Profit | $803.0M | — | +4.6% |
| R&D Expense | $56.0M | — | +0.0% |
| SG&A Expense | $472.0M | — | +2.6% |
| Operating Income | $244.0M | — | +5.6% |
| Pre-tax Income | $244.0M | — | +12.4% |
| Income Tax | $55.0M | — | +10.0% |
| Net Income | $193.0M | — | +14.2% |
| EPS (Basic) | $0.79 | — | +14.5% |
| EPS (Diluted) | $0.79 | — | +14.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $808.0M | -45.4% | -23.7% |
| Accounts Receivable | $1.80B | +2.1% | +3.0% |
| Inventory | $991.0M | +0.8% | -3.0% |
| Current Assets | $4.03B | -13.2% | -1.3% |
| Total Assets | $16.95B | -3.9% | +2.4% |
| Current Liabilities | $2.75B | -3.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $108.0M | — | +227.3% |
| Investing Cash Flow | -$76.0M | — | -406.7% |
| Financing Cash Flow | -$683.0M | — | -488.8% |
| +27.2% |
| Long-term Debt | $1.95B | -0.2% | -3.9% |
| Total Liabilities | $5.72B | -2.7% | +4.0% |
| Stockholders' Equity | $10.97B | -4.4% | +1.4% |